PMA/FDA CANDA conference
Scheduled for July 15-17 at the Sheraton Washington Hotel in Washington, D.C. Meeting on computer-assisted NDAs will focus on results of a PMA evaluation of the CANDAs submitted to date. Meeting is chaired by Upjohn Biostatistics and Clinical Data Management Exec Director John Shultz. FDA participants will include Center for Drug Evaluation and Research Deputy Director Gerald Meyer. Registration is being handled by PMA's Eldred Counts (202) 835-3547.
You may also be interested in...
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.